Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Orteronel Leaves Hole In Millennium/Takeda Pipeline

Jun 26 2014

Related Content

Takeda Has One Shot Remaining With Orteronel In Prostate Cancer

Aug 27 2013

Bayer Looks For New Partner As It Strives To Be A Player In Oncology Market

Jun 02 2014

Takeda’s Tachi Yamada Discusses The Late-Stage Pipeline: An Interview At PSA 2013

Sep 30 2013

Related Companies

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Johnson & Johnson

Amgen, Inc.

Seagen Inc.

Dendreon Corporation

Astellas Pharma, Inc.

Medivation, Inc.

Bayer AG

Additional Topics

Japan Asia Pacific Clinical Trials Strategy BioPharmaceutical

More from Japan

More from Focus On Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window